Lewes, DE -- (SBWIRE) -- 09/20/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Tullow Oil Plc (UK)(OTCMKTS:TUWOY), SBERBANK RUSSIA(OTCMKTS:SBRCY), Chancery Resources Inc(OTCMKTS:CCRY), Invivo Therapeutics Holdings Corp(OTCBB:NVIV).
Tullow Oil Plc (UK)(OTCMKTS:TUWOY) ended higher +2.37% and complete the day at $8.65. The total number of shares changed hands during the day was 158,487. After opening at $8.67, the stock hit as high as $8.71. However, it traded between $7.36 and $11.89 over the last twelve months.
Tullow Oil plc engages in the exploration, development, and production of oil and gas in Europe, South America, Asia, and Africa. It is also involved in the sale of hydrocarbons.
For How Long TUWOY will Fight for Profitability? Read This Trend Analysis report
SBERBANK RUSSIA(OTCMKTS:SBRCY) closed yesterday at $12.83, a -0.23% decrease. Around 265,847 shares were traded, low from an-average trading volume of 275,491 shares. The company is now valued at around $69.40 billion.
Sberbank provides corporate and retail banking products and services to corporate clients, small businesses, financial institutions, and individuals in the Russian Federation and internationally
Has SBRCY Found The Bottom And Ready To Gain Momentum? Find Out Here
Chancery Resources Inc(OTCMKTS:CCRY) moved +100.00 percent higher at $0.0008 and traded between $0.0004 and $0.0013 after opening the day at $0.0004. Its performance over the last five days remained 60%, which stands at 14.29% for a month. Going back further than one month, 1-year performance after recent close was -87.5%.
Chancery Resources, Inc., an exploration stage mining company, engages in the exploration of minerals. The company primarily explores for gold, silver, palladium, copper, lead, molybdenum, and zinc
For How Long CCRY Gloss will Attract Investors? Find out via this report
Invivo Therapeutics Holdings Corp(OTCBB:NVIV) shares rose, gaining +0.71 percent to close at $1.42. The stock is down around -18.39% this year and -17.44% for the last 12 months. Around 247,609 shares changed hands yesterday, lower from an-average trading volume of 1.27 million shares.
Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Why Should Investors Buy NVIV After The Recent Gain? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/